News
Modular Medical Expands Executive Team with Appointment Of Lynn O’Connor Vos as New CEO
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient AdvocacySAN DIEGO, CA / August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without...
Modular Medical Welcomes Global Healthcare Leader Lynn Vos to its Board of Directors
SAN DIEGO, CA / May 25, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, is pleased to...
Modular Medical Announces Financing
SAN DIEGO, CA / May 12, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, announced...
Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board
A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care SAN DIEGO, CA / March 18, 2021 / Modular Medical, Inc. (OTCQB: MODD), a development-stage company...
Modular Medical Relocates to Larger Corporate Headquarters
The 7,300 square foot facility features a clean-room manufacturing environment and environmentally controlled test labs SAN DIEGO, CA / March 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage company focused on the next generation of easy to use,...
Modular Medical Uplists to OTCQB Venture Market
SAN DIEGO, CA / February 18, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage company in the diabetes/insulin delivery space, today announced its successful uplisting to the OTCQB® Venture Market. Modular Medical's common stock will continue to trade...